| |
| |
|
| Insider
Information: |
Morningside Venture Investments Ltd |
| Relationship: |
|
| City: |
Mc98000 |
| State: |
O9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
20,304,365 |
|
|
Indirect Shares
|
1,000,000 |
|
|
| Direct
Value |
$545,909,414 |
|
|
|
Indirect Value
|
$299,500 |
|
|
| Total
Shares |
21,304,365 |
|
|
| Total
Value |
$546,208,914 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
19
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
3
|
19
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-19.0
|
| Percentage
Gain/Loss : |
 -11.7%
|
-1,590.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
10% Owner |
2021-11-18 |
12,806,342 |
2017-11-13 |
0 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
|
2023-08-15 |
1,947,993 |
2018-06-25 |
0 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
552,728 |
2018-07-30 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
10% Owner |
2023-08-15 |
4,997,302 |
2022-01-11 |
0 |
Premium* |
|
|
GreenLight Biosciences Holdings,... |
GRNA |
|
2023-07-24 |
0 |
2022-08-11 |
1,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-11 |
4 |
B |
$19.00 |
$5,000,002 |
D/D |
263,158 |
10,678,808 |
2.45 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,415,650 |
10,415,650 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-02-22 |
4 |
S |
$34.70 |
$1,736,352 |
D/D |
(50,000) |
7,530,598 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-02-22 |
4 |
S |
$35.91 |
$1,799,836 |
D/D |
(50,000) |
7,630,598 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-02-23 |
4 |
S |
$35.55 |
$1,778,267 |
D/D |
(50,000) |
7,580,598 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-02 |
4 |
S |
$33.75 |
$1,687,500 |
D/D |
(50,000) |
7,480,598 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-14 |
4 |
S |
$34.54 |
$2,442,462 |
D/D |
(70,714) |
7,409,884 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-15 |
4 |
S |
$33.12 |
$4,990,997 |
D/D |
(150,000) |
7,259,884 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-16 |
4 |
S |
$32.55 |
$296,921 |
D/D |
(9,122) |
7,250,762 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-21 |
4 |
S |
$31.69 |
$2,024,494 |
D/D |
(63,448) |
7,187,314 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-27 |
4 |
S |
$30.25 |
$1,859,561 |
D/D |
(60,964) |
7,126,350 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-28 |
4 |
S |
$30.37 |
$3,037,000 |
D/D |
(100,000) |
7,026,350 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
10% Owner |
– – • |
2023-08-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000,000 |
4,997,302 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2017-11-13 |
4 |
B |
$14.00 |
$8,050,000 |
D/D |
575,000 |
11,353,303 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2017-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,778,303 |
10,778,303 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2018-09-17 |
4 |
B |
$18.50 |
$742,924 |
D/D |
40,000 |
11,393,303 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2018-09-18 |
4 |
B |
$18.47 |
$738,800 |
D/D |
40,000 |
11,433,303 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2018-09-19 |
4 |
B |
$18.09 |
$1,085,400 |
D/D |
60,000 |
11,493,303 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2018-09-20 |
4 |
B |
$18.79 |
$790,363 |
D/D |
41,323 |
11,534,626 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2018-09-21 |
4 |
B |
$19.84 |
$793,600 |
D/D |
40,000 |
11,574,626 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2019-03-11 |
4 |
B |
$17.00 |
$7,499,992 |
D/D |
441,176 |
12,015,802 |
2.45 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2020-01-13 |
4 |
B |
$37.00 |
$19,999,980 |
D/D |
540,540 |
12,556,342 |
2.45 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2021-11-18 |
4 |
B |
$40.00 |
$10,000,000 |
D/D |
250,000 |
12,806,342 |
2.45 |
% |
|
| GRNA |
GreenLight Biosciences Ho... |
10% Owner |
– – • |
2022-02-02 |
4 |
B |
$0.00 |
$0 |
D/D |
1,000,000 |
13,858,188 |
2.37 |
% |
|
| GRNA |
GreenLight Biosciences Ho... |
10% Owner |
– – • |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,858,188 |
12,858,188 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
